Education
About Us
Working with TipRanks
Follow Us
Paolo De Luca Insider Profile
4 Followers
Paolo De Luca, Chief Strategy Officer at Organigram Global, holds 60.55K shares in Organigram Global (Ticker: OGI), holds 150.00K shares in Biomind Labs Inc (Ticker: TSE:BMND).
Paolo De Luca Organigram Global (OGI)Chief Strategy Officer
Organigram Global (OGI)
Chief Strategy Officer
Ranked #49,342 out of 106,487 Corporate Insiders
Profitable Transactions
11 out of 16 Profitable Transactions
Average Return
+0.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Paolo De Luca holds in companies
Most Profitable Insider Trade
The most profitable trade made by Paolo De Luca
Paolo De Luca's Trading History
Organigram Global
Dec 23, 2025
Chief Strategy Officer
Uninformative Sell
―
$84.17K
Biomind Labs Inc
Nov 30, 2009
Senior Officer
Informative Buy
13.30K
C$18.00K
List of latest transactions for each holding click on a transaction to see Paolo De Luca's performance on stock
You May Also Like
Paolo De Luca insider profile FAQ
What is the percentage of profitable transactions made by Paolo De Luca?
The percentage of profitable transactions made by Paolo De Luca is 69%.
What is the average return per transaction made by Paolo De Luca?
The average return per transaction made by Paolo De Luca is 0.20%.
What stocks does Paolo De Luca hold?
Paolo De Luca holds: OGI, TSE:BMND stocks.
What was Paolo De Luca’s latest transaction?
Paolo De Luca latest transaction was an Uninformative Sell of ―.
What was Paolo De Luca's most profitable transaction?
Paolo De Luca’s most profitable transaction was an Informative Buy of OGI stock on February 6, 2018. The return on the trade was 53.70%.
What is Paolo De Luca's role in Organigram Global?
Paolo De Luca's role in Organigram Global is Chief Strategy Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.